4.6 Article

Relationship Between Palpography and Virtual Histology in Patients With Acute Coronary Syndromes

Journal

JACC-CARDIOVASCULAR IMAGING
Volume 5, Issue 3, Pages S19-S27

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2011.02.026

Keywords

intravascular ultrasound; palpography

Funding

  1. Abbott Vascular and Volcano Corporation
  2. Volcano
  3. Abbott
  4. Adamed
  5. Biotronik
  6. Balton
  7. Bayer
  8. BBraun
  9. BioMatrix
  10. Boston Scientific
  11. Boehringer Ingelheim
  12. Bristol-Myers Squibb
  13. Cordis
  14. Cook
  15. Eli Lilly
  16. EuroCor
  17. Glaxo
  18. Invatec
  19. Medtronic
  20. Medicines Company
  21. MSD
  22. Nycomed
  23. Orbus-Neich
  24. Pfizer
  25. Possis
  26. Profiled
  27. Sanofi-Aventis
  28. Siemens
  29. Solvay
  30. Terumo
  31. Tyco
  32. InfraReDx

Ask authors/readers for more resources

OBJECTIVES The purpose of this study was to correlate adverse events at long-term follow-up in patients after an acute coronary syndrome with coronary plaque characteristics derived from simultaneous evaluation of their mechanical and compositional properties using virtual histology (intravascular ultrasound virtual histology) and palpography. BACKGROUND Fibroatheroma is the plaque morphology with the highest risk of causing adverse cardiac events. Palpography can potentially assess the local mechanical plaque properties with the possibility of identifying fibroatheroma with the highest risk of rupture. METHODS A total of 114 patients with acute coronary syndrome from the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) trial underwent a single ultrasound imaging investigation of their 3 coronary vessels with the co-registration of intravascular ultrasound virtual histology and palpography. Major adverse cardiac events (MACE) (cardiac death, cardiac arrest, myocardial infarction, or unstable or progressive angina) were collected up to a median follow-up of 3.4 years and adjudicated to originally treated culprit versus untreated nonculprit lesions. RESULTS In total, 488 necrotic core-rich plaques were identified and subclassified as thin-cap fibroatheroma (n = 111), calcified thick-cap fibroatheroma (n = 213), and noncalcified thick-cap fibroatheroma (n = 164) and matched to their co-registered palpography data. A total of 16 MACE, adjudicated to untreated nonculprit lesions, were recorded at follow-up. In patients in whom MACE developed, fibroatheroma were larger (plaque area 10.0 mm(2) [range: 8.4 to 11.6 mm(2)] vs. 8.2 mm(2) [range: 7.7 to 8.8 mm(2)] (p = 0.03) compared with patients who were MACE free. By palpography, the maximum and the density strain values did not differ between the varying subtypes of fibroatheroma of patients with or without MACE during follow-up. CONCLUSIONS In acute coronary syndromes, patients treated with stents and contemporary pharmacotherapy, palpography did not provide additional diagnostic information for the identification of fibroatheroma with a high risk of rupture and MACE during long-term follow-up. (Providing Regional Observations to Study Predictors of Events in the Coronary Tree [PROSPECT]: An Imaging Study in Patients With Unstable Atherosclerotic Lesions; NCT00180466) (J Am Coll Cardiol Img 2012;5:519-27) (C) 2012 by the American College of Cardiology Foundation

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available